Navigating compliance in harm reduction

11 minute read

The opioid epidemic—a profound public health crisis—underscores the complexities and challenges of addressing substance misuse in contemporary society. As healthcare professionals, policymakers, and communities grapple with the enormity of the crisis, the principles of harm reduction emerge as both a beacon of hope and a subject of debate. At the heart of this discussion is medication-assisted treatment (MAT), a strategy that blends the strengths of pharmacology with behavioral therapies. Yet, its implementation is riddled with legal, ethical, and regulatory challenges, painting a complex landscape for compliance professionals.

This document is only available to members. Please log in or become a member.

Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field